Clinical results with gemfibrozil and background to the Helsinki Heart Study
- 22 August 1983
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (4) , B35-B38
- https://doi.org/10.1016/0002-9149(83)90656-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up studyActa Medica Scandinavica, 1982
- Plasma Prekallikrein, Kallikrein Inhibitors, Kininogen and Lipids during Gemfibrozil Treatment in Type II DyslipidaemiaActa Medica Scandinavica, 1982
- EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASEThe Lancet, 1981
- Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.BMJ, 1981
- Gemfibrozil in the Treatment of Dyslipidaemias in Middle‐Aged Male Survivors of Myocardial InfarctionActa Medica Scandinavica, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Platelets, Intravascular Coagulation and Fibrinolysis in Hyperlipidaemias: Relationship to Thrombo‐Embolic ComplicationsActa Medica Scandinavica, 1980
- Sudden Coronary Death in ScandinaviaActa Medica Scandinavica, 1977